9,10-dimethyl-1,2-benzanthracene has been researched along with estrone in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (53.85) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 1 (3.85) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lemon, HM | 1 |
| Chattoraj, SC; Kudisch, M; Müller, RE; Wotiz, HH | 1 |
| Katoh, T; Kikuchi, Y; Kobayashi, W; Sekiya, S; Takamizawa, H; Takeda, B | 1 |
| Brodie, AM; Brodie, HJ; Marsh, D | 1 |
| Abul-Hajj, YJ | 2 |
| Horiuchi, R; Iino, Y; Maemura, M; Morishita, Y; Owada, S; Sato, H; Sugamata, N; Tago, T; Yokoe, T | 1 |
| Hayashi, K; Kosaki, G; Shimozuma, K; Tominaga, T; Yoshida, Y | 1 |
| Castanier, M; el Abed, A; Kerdelhue, B; Scholler, R | 1 |
| Jordan, VC; Robinson, SP | 1 |
| Brandau, W; Eisenhut, M; Taylor, DM | 1 |
| Brooks, SC; Corombos, J; Horwitz, JP; Hughes, DE; Hughes, R; Ludwig, EH; Odden, D; Rozhin, J; Wilson, E | 1 |
| Adams, JB; Chandra, DP; Foo, T; Li, K; Pewnim, T | 1 |
| Ip, C; Ip, MM | 1 |
| Ip, C | 1 |
| Brown, CK; Goodrich-Smith, M; Greene, HD; Hamel, EJ; Welsch, CW | 1 |
| Geng, CS; Labrie, F; Lévesque, C; Li, S; Yan, X | 1 |
| Labrie, C; Labrie, F; Lévesque, C; Li, S; Mérand, Y | 1 |
| Bélanger, A; Dauvois, S; Labrie, F; Li, S; Martel, C | 1 |
| Bradlow, HL; Osborne, MP; Suto, A; Telang, NT; Wong, GY | 1 |
| Labrie, C; Labrie, F; Luo, S; Stojanovic, M | 1 |
| Rao, BR | 1 |
| Bradlow, HL; Guo, L; Mittelman, A; Singhal, H; Tiwari, RK | 1 |
| Galfi, M; Gáspár, L; Julesz, J; Khalil, WK; Szalai, G | 1 |
| Ma, DF; Qin, LQ; Tang, FL; Wang, PY; Wang, Y; Zhou, H | 1 |
| Alonso-González, C; Alvarez-García, V; Cos, S; González, A; Martínez-Campa, C; Mediavilla, MD; Sánchez-Barceló, EJ | 1 |
1 review(s) available for 9,10-dimethyl-1,2-benzanthracene and estrone
| Article | Year |
|---|---|
Impeding estrogens and the etiology of breast cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antibodies; Embryo Implantation; Estradiol; Estradiol Congeners; Estriol; Estrogen Antagonists; Female; Humans; Hydroxyestrones; Mammary Neoplasms, Experimental; Organ Size; Pregnancy; Rabbits; Rats; Receptors, Progesterone; Uterus | 1978 |
25 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and estrone
| Article | Year |
|---|---|
Clinical and experimental aspects of the anti-mammary carinogenic activity of estriol.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Breast Neoplasms; Estriol; Estrone; Female; Humans; Neoplasms, Experimental; Rats | 1977 |
Effect of ovariectomy, adrenalectomy, and hypophysectomy on carcinogenesis of the endometrium by 7, 12-dimethylbenz[a]anthracene in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenalectomy; Animals; Castration; Estradiol; Estrone; Female; Hypophysectomy; Neoplasms, Experimental; Rats; Uterine Neoplasms | 1979 |
Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Oxidoreductases; Progesterone; Prolactin; Rats; Testosterone | 1979 |
Effect of catechol estrogens on rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Estradiol; Estriol; Estrone; Female; Hydroxyestrones; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Rats, Inbred F344 | 1979 |
Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Estradiol; Estrone; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Receptors, Estrogen; Testosterone; Uterus | 1991 |
Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrone; Fadrozole; Female; Follicle Stimulating Hormone; Imidazoles; Luteinizing Hormone; Mammary Neoplasms, Experimental; Nitriles; Prolactin; Rats; Rats, Inbred Strains; Tamoxifen | 1990 |
Stimulation of estradiol-17 beta secretion by 7,12-dimethylbenz (a) anthracene during mammary tumor induction in Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androgens; Animals; Estradiol; Estrone; Estrus; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Proestrus; Progestins; Prolactin; Rats; Rats, Inbred Strains | 1987 |
Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Drug Interactions; Estradiol; Estrenes; Estrogens; Estrone; Mammary Neoplasms, Experimental; Mifepristone; Organ Size; Progesterone; Rats; Tamoxifen | 1987 |
Synthesis and pharmacokinetics of 131I labeled benzoyl derivatives of estrone and estradiol.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Estradiol; Estrone; Female; Iodine Radioisotopes; Isotope Labeling; Kinetics; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Tissue Distribution | 1985 |
Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Castration; Estradiol; Estrogen Antagonists; Estrone; Female; Mammary Neoplasms, Experimental; Ovary; Pituitary Gland; Rats; Rats, Inbred Strains; Uterus | 1983 |
Effect of hormone manipulation on oxidation, reduction and sulphurylation of dehydroepiandrosterone and oestrone in DMBA-induced rat mammary tumours.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenine Nucleotides; Animals; Castration; Dehydroepiandrosterone; Estradiol; Estrone; Female; Mammary Neoplasms, Experimental; Oxidation-Reduction; Progesterone; Rats; Sulfates | 1980 |
Binding of catechol estrogens to the estrogen receptor of dimethylbenz(A) anthracene induced rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Nucleus; Cytosol; Estradiol; Estriol; Estrogens; Female; Hydroxyestrones; Mammary Neoplasms, Experimental; Rats; Receptors, Estrogen; Uterus | 1980 |
Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Castration; Dietary Fats; Estradiol; Estrogens; Estrone; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Receptors, Estrogen; Receptors, Progesterone | 1981 |
Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Body Weight; Diet; Dietary Fats; Estradiol; Estrone; Estrus; Female; Mammary Neoplasms, Experimental; Pregnancy; Probability; Prolactin; Rats; Selenium | 1981 |
Selenium and the genesis of murine mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Estrone; Female; Mammary Neoplasms, Experimental; Progesterone; Rats; Selenium; Species Specificity | 1981 |
Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Topics: 17-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Synergism; Estradiol; Estrenes; Estrogen Antagonists; Estrone; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Uterus | 1995 |
Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Topics: 17-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Animals; Estradiol; Estrogen Antagonists; Estrone; Female; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1995 |
Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer.
Topics: 17-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Animals; Disease Models, Animal; Estradiol; Estrone; Female; Humans; Mammary Neoplasms, Experimental; Ovariectomy; Postmenopause; Rats; Rats, Sprague-Dawley; Receptors, Progesterone | 1994 |
Genotoxic damage and aberrant proliferation in mouse mammary epithelial cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Division; Cells, Cultured; DNA Damage; DNA Repair; Epithelial Cells; Epithelium; Estradiol; Estriol; Female; Hydroxyestrones; Mammary Glands, Animal; Mice; Mice, Inbred C57BL | 1993 |
Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzopyrans; Carcinogens; Cell Division; Drug Screening Assays, Antitumor; Estrogen Antagonists; Estrone; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Organ Size; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Uterus; Vagina | 1997 |
Isolation and characterization of an estrogen binding protein which may integrate the plethora of estrogenic actions in non-reproductive organs.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antibody Specificity; Antipsychotic Agents; Binding, Competitive; Calmodulin; Chickens; Estradiol; Estriol; Estrogens; Estrone; Female; Genitalia, Female; Humans; Immunosuppressive Agents; Liver; Male; Mice; Phosphoric Monoester Hydrolases; Prostate; Rats; Receptors, Estrogen; Sulfhydryl Reagents; Tissue Distribution; Tumor Cells, Cultured | 1998 |
Endocrine characteristics of human breast epithelial cells, MCF-10F.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aromatase; Aryl Hydrocarbon Hydroxylases; Breast; Breast Neoplasms; Carcinogens; Cell Division; Cell Line; Cell Transformation, Neoplastic; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Epithelial Cells; Estradiol; Estriol; Female; Humans; Hydroxyestrones; Steroid 16-alpha-Hydroxylase; Tumor Cells, Cultured | 1999 |
Surface changes and hormone production in pituitary cells during tumorigenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acridines; Adrenocorticotropic Hormone; alpha-MSH; Animals; Carcinogens; Cell Transformation, Neoplastic; Estrone; Female; Growth Hormone; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Wistar; Tumor Cells, Cultured | 1999 |
Effect of milk on the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor model in rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Carcinogens; Cattle; Estradiol; Estrone; Female; Hormones; Mammary Neoplasms, Experimental; Milk; Organ Size; Progesterone; Rats; Rats, Sprague-Dawley | 2007 |
In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Hormonal; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrone; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Melatonin; Ovariectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfatases; Time Factors; Tumor Burden; Uterus | 2010 |